Bio-Techne Corporation
Save
11.53B
Market cap
76.36x
Current P/E
37.04x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
Similar securities
Based on sector and market capitalization
Report issue